The estimated Net Worth of Samir Kaul is at least $10.6 Milion dollars as of 14 June 2023. Mr. Kaul owns over 5,531 units of Guardant Health Inc stock worth over $283,617 and over the last 14 years he sold GH stock worth over $9,982,874. In addition, he makes $299,578 as Independent Director at Guardant Health Inc.
Samir has made over 15 trades of the Guardant Health Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently he exercised 5,531 units of GH stock worth $137,556 on 14 June 2023.
The largest trade he's ever made was selling 27,423 units of Guardant Health Inc stock on 21 November 2019 worth over $2,167,788. On average, Samir trades about 5,624 units every 154 days since 2010. As of 14 June 2023 he still owns at least 11,404 units of Guardant Health Inc stock.
You can see the complete history of Mr. Kaul stock trades at the bottom of the page.
Samir Kaul serves as Independent Director of the Company. Previously, Mr. Kaul served as a member of the board of directors of Gevo, Inc. from March 2013 to May 2014 and Amyris, Inc. from May 2006 to May 2012. Prior to that, Mr. Kaul was a member of Flagship Pioneering Inc., a venture capital firm, from June 2002 to May 2006. Prior to that, Mr. Kaul worked at the Institute for Genomic Research. Mr. Kaul holds a B.S. degree in Biology from the University of Michigan, an M.S. degree in Biochemistry from the University of Maryland and an M.B.A. degree from Harvard Business School.
As the Independent Director of Guardant Health Inc, the total compensation of Samir Kaul at Guardant Health Inc is $299,578. There are 10 executives at Guardant Health Inc getting paid more, with Michael Wiley having the highest compensation of $2,216,070.
Samir Kaul is 46, he's been the Independent Director of Guardant Health Inc since 2014. There are 8 older and 7 younger executives at Guardant Health Inc. The oldest executive at Guardant Health Inc is Stanley Meresman, 73, who is the Independent Director.
Samir's mailing address filed with the SEC is 3100, Hanover Street, Palo Alto, Santa Clara County, California, 94306, United States.
Over the last 6 years, insiders at Guardant Health Inc have traded over $2,653,630,540 worth of Guardant Health Inc stock and bought 2,438,210 units worth $45,173,576 . The most active insiders traders include Bluebird (Cayman) Ltd Softb..., Bluebird (Cayman) Ltd Svf E... oraz Helmy Eltoukhy. On average, Guardant Health Inc executives and independent directors trade stock every 6 days with the average trade being worth of $2,415,822. The most recent stock trade was executed by Kumud Kalia on 9 September 2024, trading 6,545 units of GH stock currently worth $162,774.
we believe conquering cancer is a big data problem. that’s why we built the world’s leading comprehensive liquid biopsy. this non-invasive tool for accessing and sequencing tumor dna is used by thousands of oncologists to help tens of thousands of advanced cancer patients. we believe the boom in cancer data acquisition we helped launch will drive important discoveries and new products. we’re working on some exciting ones, including in early detection, where the impact on patients can be profound. we’ve raised more than $500 million from investors including sequoia capital, khosla ventures, orbimed, and softbank.
Guardant Health Inc executives and other stock owners filed with the SEC include: